Australian Institute of Health and Welfare (2022) Mental health services in Australia, AIHW, Australian Government, accessed 03 July 2022.
Australian Institute of Health and Welfare. (2022). Mental health services in Australia. Retrieved from https://www.aihw.gov.au/reports/mental-health-services/mental-health-services-in-australia
Mental health services in Australia. Australian Institute of Health and Welfare, 17 May 2022, https://www.aihw.gov.au/reports/mental-health-services/mental-health-services-in-australia
Australian Institute of Health and Welfare. Mental health services in Australia [Internet]. Canberra: Australian Institute of Health and Welfare, 2022 [cited 2022 Jul. 3]. Available from: https://www.aihw.gov.au/reports/mental-health-services/mental-health-services-in-australia
Australian Institute of Health and Welfare (AIHW) 2022, Mental health services in Australia, viewed 3 July 2022, https://www.aihw.gov.au/reports/mental-health-services/mental-health-services-in-australia
Get citations as an Endnote file:
This section reviews the available information on recurrent expenditure (running costs) for mental health-related services in Australia. Health expenditure (what was spent) and health funding (funding provided and who provided the funds) are distinct but related concepts essential to understanding the financial resources used by the health system. Data on expenditure and funding, calculated in both current and constant prices, are derived from a variety of sources, as outlined in the data source section.
Data presented in this section is for the 2019–20 period, constant prices are adjusted to 2019–20 levels. Further information on health spending is also available in Health Expenditure Australia 2019–20 (AIHW 2021).
Expenditure on mental health-related services 2019–20 tables (534KB XLSX)
Expenditure on mental health-related services 2019–20 section (443KB PDF)
Data source and key concepts related to this section
Data coverage includes the time period 1992–93 to 2019–20. Australian Government Medicare expenditure and mental health-related medications subsidised under the PBS and RPBS expenditure data for 2019–20 in this section were last updated in May 2021.
You may also be interested in:
Specialised mental health care facilities
In 2019–20, the national recurrent spending on mental health-related services was estimated to be $11.0 billion. This represents an annual average increase of 3.0% since 2015–16, in real terms (i.e. adjusted for inflation). Overall, national expenditure on mental health-related services increased from $409 per Australian in 2015–16 to $431 per person during 2019–20; an average annual increase of 1.3% in real terms.
Of the $11.0 billion spent nationally in 2019–20, state and territory governments spent 60.0% ($6.6 billion), the Australian Government 34.7% ($3.8 billion), and private health insurance funds and other third party insurers 5.3% ($584 million). These proportions have remained relatively stable over time, with 60.4% of national spending coming from state and territory governments, 34.4% from the Australian Government, and 5.2% from private health insurance funds and other insurers in 2015–16.
Government spending on mental health-related services in 2019–20 was estimated to be around 7.6% of total government health expenditure, in line with 2015–16 (7.6%) and up from 7.3% in 1992–93 when data collection began.
Spending by the Australian Government for mental health-related services (adjusted for inflation) has increased by an average annual rate of 3.2% over the period 2015–16 to 2019–20, while spending by state and territory governments increased by an average annual rate of 2.8%.
Around $6.7 billion was spent on state and territory specialised mental health services in 2019–20. The largest proportion of this spending was on public hospital services for admitted patients ($2.9b), comprising of public acute hospitals with a specialist psychiatric unit or ward ($2.3b) and public psychiatric hospitals ($0.6b). This was closely followed by spending on community mental health care services totalling almost $2.6b.
Per capita spending on specialised mental health services ranged from $247 per person in Queensland to $328 per person in the Northern Territory, compared to a national average of $260 per person during 2019–20.
Per capita spending on state and territory specialised mental health services increased in real terms by an average annual rate of 1.0% between 2015–16 and 2019–20. This equates to an increase of about $10 per person, from about $250 in 2015–16 to about $260 in 2019–20.
Detailed spending data are available covering more than 25 years to 2019–20. Figure EXP.1 shows the changes in state and territory spending patterns, for example, increased investment in community mental health care services, reflecting changes to the state and territory specialised mental health service profile mix over this time. Further information can be found in the Specialised mental health care facilities section.
Stacked area chart showing the per capita spending on specialised mental health services from 1992–93 to 2019–20. Public psychiatric hospital spending has decreased over the period. Spending increased for specialised psychiatric units of wards in public hospitals, community mental health care services, residential mental health services, grants to non-government-organisations and other indirect expenditure. Refer to Table EXP.4.
Sources: Australian Government Department of Health, National Survey of Mental Health Services Database (1992–93 to 2004–05), National Mental Health Establishments Database (2005–06 onwards); Table EXP.4.
Source data: Expenditure on mental health-related services 2019–20 tables (534KB XLSX)
The majority (96.5% or $6.4 billion of the $6.7 billion total cost) of funding for state and territory specialised mental health services was provided by state or territory governments in 2019–20. However, this estimate does not take into account the Australian Government payments to jurisdictions for the running of public hospital services which includes the community-based clinical services managed by public hospitals. Refer to the data source section for technical information regarding Australian Government expenditure.
The $2.9 billion of recurrent expenditure for public sector specialised mental health hospital services during 2019–20 equates to an average cost per patient day of $1,277. The Northern Territory ($1,674) had the highest average cost per patient day and Queensland ($1,093) was the lowest.
Recurrent expenditure on public sector specialised mental health hospital services can be further described using target population (General, Child and adolescent, Youth, Older person and Forensic target groups), program type (acute and non-acute) or a combination of these.
Mental health services classified as having a General target population ($2.1 billion or 72.5%) accounted for the majority of recurrent spending for public sector specialised mental health hospital services during 2019–20. Child and adolescent services ($2,548 per patient day) had the highest costs per patient day, continuing a long term trend of these services costing more to run than services with General target population ($1,247 per patient day), Older person ($1,124 per patient day) and Forensic ($1,318 per patient day) services.
There was an average annual increase in spending per patient day for General (1.5%), Child and adolescent (2.2%), Older person services (3.7%), and Forensic services (2.9%) between 2015–16 and 2019–20, in real terms.
Average patient day costs for acute public sector specialised mental health hospital services at the national level were higher than those for non-acute services for all target population categories in 2019–20.
Community mental health care services accounted for almost $2.6 billion of recurrent spending on mental health services during 2019–20, representing 38.6% of total state and territory spending.
Of the $420 million spent on residential mental health services during 2019–20, the majority was spent on 24-hour staffed services ($383m or 91.1%). General services ($293m) accounted for more than two thirds (69.8%) of the total residential spending.
The average national cost per patient day for residential mental health services was $583 per day in 2019–20. Average costs varied between states and territories, ranging from $369 per patient day in Western Australia to $759 per patient day in Queensland.
Recurrent spending for public sector specialised mental health hospital, community and residential services can be combined and presented by target population. Spending on General services ($258 per person) was the highest of the 5 target populations during 2019–20, reflecting that many jurisdictions do not have the other specialised target population hospital services which contribute substantial costs to the overall spending profile. In real terms, General, Child and adolescent and Forensic services have had moderate per capita spending increases between 2015–16 and 2019–20 while per capita spending on Youth services increased by an average of 13% per year. Over this time period, per capita spending on Older person services decreased by an average of 1.0% per year, which reflects the fact that Older persons services have not increased to the same extent as the increases in the size of the Older persons population. For example, while the real spending on Older person services had an annual average increase of 2.3% to $630 million between 2015–16 and 2019–20, the Older person population (65 years and over) increased by 14.1% to 4.1 million people over the same period.
Total spending on specialised mental health private hospital services was $805 million in 2019–20, and the non-Commonwealth sourced component of this revenue was $584m. Adjusted for inflation, these represent annual average increases from 2015–16 of 3.5% and 3.2% per year respectively. Spending on specialised mental health services in private hospitals has not been available since 2017–18 due to changes in how the data is collected.
Australian Government spending on mental health-related services was estimated to be $3.8 billion in 2019–20. However, as noted previously and detailed in the data source section of this report, there are other known Australian government outlays attributable to supporting mental health issues which are not included in this estimate.
Australian Government spending on mental health-related services, in real terms, increased by an average annual rate of 3.2% between 2015–16 and 2019–20. This equates to an annual average increase of 1.6% in real terms, from $141 per person in 2015–16 to $150 in 2019–20. Changes in PBS/RPBS spending impacted the overall change, declining by around $3 per person over this time frame, specifically due to spending on antipsychotics and antidepressants declining by about $2 per capita respectively. This was likely the result of a decrease in the subsidised cost of some medications, partly due to some medications no longer being under patent.
Spending on MBS-subsidised mental health-specific services and mental health-related medications provided through the PBS accounted for 50.0% of the total Australian Government spending on mental health-related services in 2019–20 (Figure EXP.2). This was followed by:
Since 2008–09, there has been an overall decrease in the Government cost of PBS mental health-related prescriptions and an increase in Government spending on MBS-subsidised services and programs and National programs and initiatives. Medication prices can reduce for a variety of factors (for example, Price Disclosure or statutory price reductions due to patent changes - legislation mandated by the Government to reduce the PBS listed price of drugs), refer to the Mental health-related prescriptions section and PBS.gov.au for more information on the Pharmaceutical Benefits Scheme (PBS) or Repatriation Pharmaceutical Benefits Scheme (RPBS). Technical information regarding the calculation of these figures can be found in the data source section.
Stacked vertical bar chart showing the per capita spending by the Australian Government on specialised mental health services between 2009–10 and 2019–20. Expenditure increased for Mental health specific payments to states and territories, National programs and initiatives, the National Mental Health Commission and private health insurance premium rebates. Expenditure decreased for the Pharmaceuticals Benefit Scheme and research. Refer to Table EXP.31.
Note: National programs and initiatives includes: programs managed by DoH, programs managed by DSS, programs managed by DVA, DoD funded programs, Indigenous social and emotional wellbring programs, National Suicide Prevention Program.
Source: Australian Government Department of Health (unpublished); Table EXP.31
Australian Government spending on Department of Defence funded mental health programs has increased by an average of 2.0% per year for the period 2015–16 ($50.2 million) to 2019–20 ($54.3m), in real terms. The spending covers a range of mental health programs and services delivered to Australian Defence Force (ADF) personnel. When the number of permanent ADF personnel is taken into consideration (59,760 people; Department of Defence 2020) this equates to $909 per permanent ADF member in 2019–20.
Medicare-subsidised mental health-specific services refers to the mental health-specific services subsidised by the Australian Government through the Medicare Benefits Schedule (MBS). These services include mental health-specific services provided by psychiatrists, general practitioners (GPs), psychologists (both clinical and other) and other allied health professionals and are defined in the MBS. Refer to the data source section for further information on the estimation of GP spending prior to 2007–08.
In 2019–20, $1.4 billion was paid in benefits for Medicare-subsidised mental health-specific services, equating to 5.4% of total MBS spending ($25.0b - including Dental Benefits Schedule and the Child Dental Benefits Schedule) (SA 2020). Spending for services provided by psychologists ($609 million or 45.0%) made up the largest proportion, comprising mostly Psychological Therapy Services (clinical psychologists; $334m) and Focussed Psychological Strategies (other psychologists; $275m). Spending on services provided by psychiatrists was the next largest group ($389m or 28.8%). GP spending comprised $317m (23.4%) of total Medicare-subsidised mental health-related benefits.
Nationally, benefits paid for Medicare-subsidised mental health-related services averaged $53 per person in 2019–20, a small increase on the $51 per person in 2018–19 (in real terms compared to 2018–19 prices) (Figure EXP.3). The average benefits paid per person was highest in Victoria ($58 per person, in real terms), and lowest in the Northern Territory ($17 per person).
Stacked vertical bar chart showing the Australian Government per capita expenditure on Medicare-subsidised mental health-specific services by provider type and states and territories in 2019–20. There was no consistent trend across the states and territories as to which provider had the highest per capita expenditure, with psychiatrists, clinical psychologists and general practitioners all having the highest per capita expenditure in at least one state or territory. Per capita expenditure for Other allied health was the lowest of all providers in every state and territory.
Note: ‘Clinical psychologist’ refers to psychological therapy services provided by a clinical psychologist, and ‘Other psychologist’ includes other psychology services involving clinical psychologists and other psychologists.
Source: Medicare Benefits Schedule data; Table EXP.20.
There was an average annual increase of 3.6% in the total spending on Medicare-subsidised mental health-specific services (adjusted for inflation) between 2015–16 and 2019–20. This change equates to an average annual increase (per person) in spending of 2.0%, in real terms, from $48 in 2015–16 to $52 in 2019–20.
Australian Government spending on mental health-related subsidised prescriptions under the PBS and RPBS was $566 million, or $22 per person in the Australian population, in 2019–20. This was equivalent to 4.4% of all PBS and RPBS subsidies ($13.0 billion) (SA 2020). Prescriptions for antipsychotics (48.1%) and antidepressants (32.5%) accounted for the majority of mental health-related PBS and RPBS spending in 2019–20, followed by prescriptions for psychostimulants, agents used for Attention-deficit hyperactivity disorder (ADHD) and nootropics (13.1%), anxiolytics (4.1%) and hypnotics and sedatives (2.2%).
In 2019–20, Tasmania ($28 per person) had the highest per capita cost of PBS/RPBS medications, and the Northern Territory ($14) the lowest, compared with the national per capita cost of $22 (Figure EXP.4). For most states and territories, the cost of antipsychotics was the largest proportion of PBS/RPBS costs, followed by antidepressants, except for Tasmania where the cost of antidepressants was slightly more than antipsychotics.
Stacked vertical bar chart showing the Australian Government per capita expenditure on mental health-related medications subsidised under the PBS/RPBS by type of medication prescribed and states and territories in 2019–20. The highest per capita spend was on Antipsychotics in all states and territories, except for Tasmania where Antidepressants was the highest. Hypnotics and sedatives had the lowest per capita spend across all states and territories. Refer to Table EXP.28.
Source: Pharmaceutical Benefits Scheme data; Table EXP.28.
Over two-thirds (69.3% or $375 million) of the spending on mental health-related subsidised prescriptions was for prescriptions issued by GPs. This was followed by prescriptions written by psychiatrists (16.3% or $88m), with non-psychiatrist specialists’ prescriptions accounting for 9.2% ($50m).
Real expenditure (constant prices) for mental health-related prescriptions declined between 2014–15 and 2019–20, from $708m to $541m. This was the result of a decrease in the subsided cost of some medications rather than a reduction in prescribing. The subsidised and total number of mental health-related prescriptions grew at annual average rates of 0.4% and 3.2% per year respectively over this period (see table PBS.7). Medication prices can reduce for a variety of reasons (for example, Price Disclosure); refer to the Mental health-related prescriptions section for more information.
We'd love to know any feedback that you have about the AIHW website, its contents or reports.
The browser you are using to browse this website is outdated and some features may not display properly or be accessible to you. Please use a more recent browser for the best user experience.